Why does CRISPR randomly fail 15% of the time?

crispr mutations copy
Image credit: Nature

The CRISPR gene editing process is known to fail about 15 percent of the time. These random failures have until now been a mystery to scientists who consistently work with the technique. When the technique is working properly, an enzyme called Cas9 is what actively makes the cuts to a desired position in a DNA strand. After the cut is made either a new desired sequence is added or an unwanted section is simply removed, with the two cut points gluing themselves back together.

The new research revealed that when the CRISPR process fails it is because the Cas9 enzyme effectively sticks to the DNA cut point, blocking the subsequent DNA repair process.

The study also found that when RNA polymerases collide with Cas9 they can force the enzyme to dislodge. This means that consistent strand selection can significantly improve the genome editing technique’s efficiency.

“I was shocked that simply choosing one DNA strand over the other had such a powerful effect on genome editing,” says Ryan Clarke, lead author of the study. “Uncovering the mechanism behind this phenomenon helps us better understand how Cas9 interactions with the genome can cause some editing attempts to fail and that, when designing a genome editing experiment, we can use that understanding to our benefit.”

Read full, original post: Researchers discover why the CRISPR gene editing system sometimes fails

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
Screenshot 2026-05-11 at 11.30
Despite politicized disinformation, Midwest AI data centers are fueling a solar energy boom
Screenshot-2026-05-08-at-11.55.47-AM
Anti-vax activists falsely blame COVID vaccines for the rising U.S. cancer rate among younger people.
Screenshot-2026-05-08-at-3.40.33-PM
Seeds of power: China turns to genetic engineering to become global superpower
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.